Cargando…

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study

OBJECTIVE: Given that the Women’s Health Initiative reported in 2002 increased risks of breast cancer and cardiovascular events with hormone therapy (HT) use and many women discontinued use, we assessed the use and perceived efficacy of complementary and alternative medicines (CAMs) for menopausal s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentry-Maharaj, Aleksandra, Karpinskyj, Chloe, Glazer, Clara, Burnell, Matthew, Ryan, Andy, Fraser, Lindsay, Lanceley, Anne, Jacobs, Ian, Hunter, Myra S., Menon, Usha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott-Raven Publishers 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470524/ https://www.ncbi.nlm.nih.gov/pubmed/25290539 http://dx.doi.org/10.1097/GME.0000000000000330

Ejemplares similares

Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening
por: Gentry-Maharaj, A., et al.
Publicado: (2017)

Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested Within UKCTOCS
por: Karpinskyj, Chloe, et al.
Publicado: (2020)

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Pennington, Mark, et al.
Publicado: (2016)

Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Bailey, Katharine, et al.
Publicado: (2015)

Serial endometrial thickness and risk of non‐endometrial hormone‐dependent cancers in postmenopausal women in UK Collaborative Trial of Ovarian Cancer Screening
por: Burnell, M., et al.
Publicado: (2020)

Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Trembling, Paul M, et al.
Publicado: (2017)

Audit of transvaginal sonography of normal postmenopausal ovaries by sonographers from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Stott, Will, et al.
Publicado: (2018)

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2017)

Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Thomas, Darren S., et al.
Publicado: (2019)

Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Dilley, James, et al.
Publicado: (2020)

Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2014)

Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Fourkala, Evangelia-Ourania, et al.
Publicado: (2014)

Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Sharma, A., et al.
Publicado: (2016)

UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis
por: Burnell, Matthew, et al.
Publicado: (2021)

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
por: Fourkala, E O, et al.
Publicado: (2012)

Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar
por: Kalsi, Jatinderpal K., et al.
Publicado: (2021)

Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
por: Gentry-Maharaj, A, et al.
Publicado: (2013)

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer
por: Datta, Soumitra Shankar, et al.
Publicado: (2022)

Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS)
por: Trembling, P. M., et al.
Publicado: (2018)

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Cancer-associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening
por: Pedersen, Johannes W, et al.
Publicado: (2014)

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Menon, Usha, et al.
Publicado: (2021)

Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Kalsi, Jatinderpal, et al.
Publicado: (2021)

The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
por: Trembling, Paul M., et al.
Publicado: (2020)

Ovarian cancer screening—Current status, future directions()
por: Menon, Usha, et al.
Publicado: (2014)

Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening
por: Menon, Usha, et al.
Publicado: (2015)

Serial Patterns of Ovarian Cancer Biomarkers in a Prediagnosis Longitudinal Dataset
por: Blyuss, Oleg, et al.
Publicado: (2015)

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
por: Timms, John F., et al.
Publicado: (2014)

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women
por: Fourkala, Evangelia-Ourania, et al.
Publicado: (2012)

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
por: Rosenthal, Adam N., et al.
Publicado: (2017)

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Menon, Usha, et al.
Publicado: (2017)

A quantitative performance study of two automatic methods for the diagnosis of ovarian cancer
por: Vázquez, Manuel A., et al.
Publicado: (2018)

Identifying hopelessness in population research: a validation study of two brief measures of hopelessness
por: Fraser, Lindsay, et al.
Publicado: (2014)

Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
por: Pedersen, J W, et al.
Publicado: (2013)

Improved early detection of ovarian cancer using longitudinal multimarker models
por: Whitwell, Harry J., et al.
Publicado: (2020)

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Jacobs, Ian J, et al.
Publicado: (2016)

Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
por: Kazarian, Anna, et al.
Publicado: (2017)

Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel
por: Russell, Matthew R., et al.
Publicado: (2019)

A combined biomarker panel shows improved sensitivity for the early detection of ovarian cancer allowing the identification of the most aggressive type II tumours
por: Russell, Matthew R, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rs7bc01v4hnuau4guldd35m6r2